Ciby Abraham, PhD, Senior Director and Group Manager, Project and Product Leadership, AstraZeneca, is Committee Chair for the 2025 ISPE Annual Meeting & Expo, ISPE’s largest event of the year. The event will take place 26–29 October in Charlotte, North Carolina, USA.
2025 ISPE Annual Meeting & Expo: What We Will Discuss
In the video above, Abraham shares that one of the discussions he looks forward to most is the Global Regulatory Town Hall. This session will bring industry leaders together with senior leaders from health authorities to discuss challenging questions such as, “How will AI/machine learning be incorporated in delivering the next generation of medicines more efficiently and effectively to patients all around the world?”
“Another topic of great interest is decentralized manufacturing,” shares Abraham. This is an opportunity to hear from the Medicines and Healthcare products Regulatory Agenda (MRHA), the regulatory body in the United Kingdom (UK) that is responsible for ensuring that medicines and medical devices are safe and effective for public use, on “how they came up with their model of manufacturing and supply and how they engaged with industry, academia, healthcare professionals, and international regulators to develop their framework.”
2025 ISPE Annual Meeting & Expo: What You Will Learn
In the video above, Abraham shares, “The attendees for this conference have an amazing opportunity to interact with industry and regulatory experts where they can gain practical knowledge on leveraging automation, AI, and analytics, which could potentially help them optimize pharmaceutical workflows, drive continuous improvement, and most importantly, learn strategies to accelerate digital transformation in manufacturing and quality operations to bring back to their companies.”>
18 - 21 October 2026 Washington, DC USA and Virtual
A Call to Engage
The 2026 ISPE Annual Meeting & Expo will unite pharmaceutical and biopharmaceutical professionals for critical discussions and networking. The program features technical sessions on sustainability, operations, supply chain, and innovations. Attendees can connect with industry leaders and explore the latest technologies and services in the Expo Hall.
Katie is a public relations and communications strategist with 15+ years of experience working hand-in-hand with organizations to develop and implement overarching communications strategies that...
As the pharmaceutical industry navigates evolving regulatory expectations, emerging technologies, sustainability goals, and increasingly complex global supply networks, professionals need more than presentations and panel discussions. They need opportunities to engage directly with experts, test new ideas, and develop practical solutions they can bring back to their organizations.
AI is entering GxP-regulated environments—but simple answers are proving elusive. As guidance evolves and the technology advances rapidly, organizations face critical questions: how much control is enough, and what does enough control look like? This blog post challenges “catch-all” thinking and makes the case for a contextual, life cycle-focused approach to AI controls, prioritizing judgment,...
AI is everywhere these days—it’s impacting everything from how we plan our vacations, to what we see online, and perhaps how we attack our email inbox. How is it impacting drug development, and how are global regulatory agencies adapting to the use of AI? ISPE’s Regulatory Quality Harmonization Committee’s Asia Pacific Regional Focus Group has reviewed a few recent AI-related guidances from...
